posted on Dec, 8 2009 @ 11:54 PM
Filing under the "we always suspected" category:
This is a confidential pharmaceutical industry trade association dossier about the WHO Expert Working Group (EWG) on R&D Financing.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA; "Big Pharma") gave its members 4 documents: a non-public draft
report of the WHO EWG and a non-public Comparative Analysis done by the working group, the IFPMA Overview of the EWG
Comparative Analysis, and IFPMA summary slide on the EWG Draft Report.
The compilation of documents shows the influence of "Big Pharma" on the policy making decisions of the WHO, the UN body safeguarding public
health. These confidential documents were obtained by the drug industry before their public release to WHO member states (scheduled to be released
May 2010). The document also illustrates that the WHO expert group was highly responsive to industry lobbying — a result that public health
groups had feared since early 2009, when the expert group met with the industry, but refused to meet with public health groups known to be industry
The likely audience for these documents include countries, public health policy makers, civil society, industry, academia, media, patients and the
The very interesting PDF documentation available for download at above link.
Just wanted to post this for discussion, I will add further comment as I sift through the voluminous material.
And once again a huge thumbs up at our friends at wikileaks.
Edit to add link:
[edit on 9 Dec 2009 by schrodingers dog]